We are live on
!
Find out more
AA
ALPS Advisors Portfolio holdings
AUM
$21.3B
1-Year Est. Return
21.71%
This Fund
S&P 500
This Quarter
Est. Return
+1.29%
1 Year Est. Return
+21.71%
3 Year Est. Return
+77.63%
5 Year Est. Return
+121.1%
10 Year Est. Return
+198.29%
AUM
$8.89B
AUM Growth
-$1.49B
(-14%)
Cap. Flow
-$1.55B
Cap. Flow
% of AUM
-17.42%
Top 10 Holdings %
Top 10 Hldgs %
47.67%
Holding
1,012
New
106
Increased
478
Reduced
302
Closed
124
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Energy Transfer Partners
ET
|
+$37.3M |
| 2 |
MMP
Magellan Midstream Partners, L.P.
MMP
|
+$31.1M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$27.8M |
| 4 |
Newmont
NEM
|
+$27.4M |
| 5 |
Cummins
CMI
|
+$24.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class A
BRK.A
|
+$430M |
| 2 |
JPMorgan Chase
JPM
|
+$168M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$132M |
| 4 |
Yum! Brands
YUM
|
+$105M |
| 5 |
Pfizer
PFE
|
+$92.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 59.33% |
| 2 | Technology | 6.01% |
| 3 | Healthcare | 4.63% |
| 4 | Consumer Discretionary | 3.72% |
| 5 | Financials | 3.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TPIC
151
DELISTED
TPI Composites
TPIC
| $4.87M | 0.05% |
325,392
-12,446
| -4% | -$305K |
|
152
Thermo Fisher Scientific
TMO
$211B
| $4.8M | 0.05% |
7,195
+99
| +1% | +$61.8K |
|
153
Texas Instruments
TXN
$255B
| $4.68M | 0.05% |
24,830
+13,685
| +123% | +$2.63M |
|
|
KRTX
154
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $4.49M | 0.05% |
34,281
-1,938
| -5% | -$250K |
|
|
HYZN
155
DELISTED
Hyzon Motors Inc. Class A Common Stock
HYZN
| $4.44M | 0.05% |
+13,675
| New | +$4.46M |
|
156
Fidelity National Information Services
FIS
$21.5B
| $4.43M | 0.05% |
40,640
+3,259
| +9% | +$368K |
|
157
Cytokinetics
CYTK
$11B
| $4.42M | 0.05% |
97,071
-5,283
| -5% | -$204K |
|
158
Alkermes
ALKS
$8.82B
| $4.36M | 0.05% |
187,586
-10,620
| -5% | -$279K |
|
159
Acadia Pharmaceuticals
ACAD
$4.25B
| $4.34M | 0.05% |
186,044
-10,850
| -6% | -$218K |
|
|
LKFT
160
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.82B
| $4.21M | 0.05% |
+76,280
| New | +$3.98M |
|
161
Broadcom
AVGO
$1.82T
| $4.15M | 0.05% |
62,360
-16,610
| -21% | -$934K |
|
|
SA
162
Seabridge Gold
SA
$2.8B
| $4.1M | 0.05% |
248,422
+118,468
| +91% | +$2.12M |
|
|
163
Pfizer
PFE
$140B
| $4.08M | 0.05% |
69,056
-1,872,788
| -96% | -$92.8M |
|
164
Merck
MRK
$324B
| $4.03M | 0.05% |
52,570
-290,481
| -85% | -$23.1M |
|
165
Truist Financial
TFC
$63.2B
| $3.86M | 0.04% |
+65,852
| New | +$4.02M |
|
166
Opko Health
OPK
$921M
| $3.79M | 0.04% |
+788,530
| New | +$3.19M |
|
167
Salesforce
CRM
$134B
| $3.74M | 0.04% |
14,712
+225
| +2% | +$63.2K |
|
168
Insmed
INSM
$23.2B
| $3.73M | 0.04% |
+136,994
| New | +$3.92M |
|
|
FOLD
169
DELISTED
Amicus Therapeutics
FOLD
| $3.73M | 0.04% |
322,468
-4,242
| -1% | -$47.3K |
|
170
Carlyle Group
CG
$16.3B
| $3.72M | 0.04% |
67,697
-203
| -0.3% | -$11.1K |
|
|
PPLI
171
People Inc
PPLI
$3.1B
| $3.64M | 0.04% |
33,949
-2,267
| -6% | -$256K |
|
172
Duke Energy
DUK
$102B
| $3.6M | 0.04% |
+34,351
| New | +$3.48M |
|
173
US Bancorp
USB
$99.6B
| $3.56M | 0.04% |
+63,384
| New | +$3.75M |
|
|
LSXMA
174
DELISTED
Liberty Media Corporation Series A Liberty SiriusXM Common Stock
LSXMA
| $3.54M | 0.04% |
94,726
-816
| -0.9% | -$30.1K |
|
175
Bank of America
BAC
$435B
| $3.54M | 0.04% |
79,460
+3,913
| +5% | +$178K |
|
Similar funds
PAG
MMH
IC
DSA
VARA
SC
CB
ALPS Advisors's Q4 2021 Portfolio in Review
As of Q4 2021, ALPS Advisors held 1,012 positions worth $8.89B, down 14% from $10.4B the previous quarter. Its ten largest holdings account for 48% of the portfolio.
ALPS Advisors withdrew a net $1.55B in Q4 2021, closing 124 positions and reducing 302 holdings. Its most notable exit was Berkshire Hathaway Class A, an estimated $430M position sold in full.
By sector, the portfolio is most concentrated in Energy at 59% of assets, up from 51% a quarter earlier, followed by Technology and Healthcare.
Against the trend, ALPS Advisors opened a new position in Bristol-Myers Squibb worth $29.6M.
- ALPS Advisors's largest Q4 2021 buy was Bristol-Myers Squibb: 474,459 shares worth $29.6M.
- ALPS Advisors added most to Energy Transfer Partners in Q4 2021, an estimated $37.3M increase.
- ALPS Advisors's biggest Q4 2021 reduction was JPMorgan Chase, cutting an estimated $168M.
- ALPS Advisors fully exited Berkshire Hathaway Class A in Q4 2021, selling an estimated $430M.
- ALPS Advisors's ten largest holdings make up 48% of its $8.89B portfolio in Q4 2021.
- ALPS Advisors opened 106 new positions and closed 124 in Q4 2021.
- ALPS Advisors's portfolio value fell 14% quarter-over-quarter to $8.89B.
Based on ALPS Advisors's 13F filing for Q4 2021, filed 9 Feb 2022.